T Kawakami Selected Research

T Kawakami Research Topics

Disease

11	Neoplasms (Cancer) 01/2021 - 12/2000
3	Bullous Pemphigoid (Pemphigoid) 01/2021 - 06/2013
3	Aneurysm (Aneurysms) 07/2018 - 04/2000
3	Bronchiolitis Obliterans 09/2017 - 06/2013
3	Purpura 10/2013 - 11/2006
3	Hypersensitivity (Allergy) 10/2001 - 06/2001
2	Pemphigus (Pemphigus Vulgaris) 07/2015 - 06/2013
2	Vasculitis (Vasculitides) 06/2012 - 11/2006
2	Ameloblastoma 04/2010 - 10/2008
2	Pruritus (Itching) 09/2009 - 01/2001
2	Temporomandibular Joint Disorders (Temporomandibular Joint Disorder) 01/2009 - 05/2006
2	Systemic Scleroderma (Systemic Sclerosis) 12/2007 - 11/2000
2	Osteosarcoma (Osteogenic Sarcoma) 11/2005 - 11/2004
2	Inflammation (Inflammations) 10/2001 - 04/2001
2	Carcinogenesis 05/2001 - 04/2001
2	Bowen's Disease (Disease, Bowen) 04/2001 - 01/2001
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Rupture 07/2018
1	Necrosis 10/2013
1	Nephritis 10/2013
1	Respiratory Insufficiency (Respiratory Failure) 06/2013
1	Microscopic Polyangiitis 06/2012
1	Dental Caries (Decay, Dental) 01/2011
1	Radicular Cyst 03/2010
1	Gingival Overgrowth 11/2009
1	Erectile Dysfunction 11/2009
1	Nausea 09/2009
1	Hypesthesia (Numbness) 09/2009
1	Vomiting 09/2009
1	Pain (Aches) 09/2009
1	Carcinoma (Carcinomatosis) 10/2008
1	Quadriplegia (Spastic Quadriplegia) 07/2008
1	Exanthema (Rash) 07/2008
1	Adenocarcinoma of Lung 02/2008

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 02/2008 - 01/2001
4	EnzymesIBA 12/2015 - 05/2001
4	AntibodiesIBA 07/2015 - 10/2001
4	Immunoglobulin A (IgA)IBA 10/2013 - 11/2006
4	Peptides (Polypeptides)IBA 10/2008 - 04/2004
3	Indicators and Reagents (Reagents)IBA 07/2018 - 04/2001
3	AutoantibodiesIBA 07/2017 - 11/2006
3	Immunoglobulin G (IgG)IBA 07/2015 - 04/2004
3	Messenger RNA (mRNA)IBA 10/2008 - 03/2001
2	Pharmaceutical PreparationsIBA 01/2021 - 06/2000
2	SiliconesIBA 07/2018 - 08/2016
2	Immunoglobulin E (IgE)IBA 07/2017 - 06/2001
2	ImmunosorbentsIBA 12/2015 - 07/2015
2	DesmocollinsIBA 07/2015 - 06/2013
2	Antiphospholipid AntibodiesIBA 10/2013 - 11/2006
2	Anticardiolipin AntibodiesIBA 10/2013 - 11/2006
2	AntigensIBA 06/2013 - 05/2001
2	Antigen-Antibody Complex (Immune Complex)IBA 06/2012 - 11/2006
2	Therapeutic UsesIBA 11/2009 - 11/2007
2	RNA (Ribonucleic Acid)IBA 10/2001 - 05/2001
2	AngiopoietinsIBA 05/2001 - 02/2001
2	Interleukin-10 (Interleukin 10)IBA 05/2001 - 03/2001
2	Transforming Growth Factor beta3 (TGF beta 3)IBA 04/2001 - 11/2000
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2021
1	Laminin (Merosin)IBA 01/2021
1	regorafenibIBA 01/2021
1	trifluridine tipiracil drug combinationIBA 01/2021
1	NivolumabIBA 01/2021
1	PerforinIBA 09/2017
1	PolymersIBA 08/2016
1	Desmoglein 3IBA 12/2015
1	Cadherins (E-Cadherin)IBA 07/2015
1	DesmogleinsIBA 07/2015
1	Recombinant ProteinsIBA 07/2015
1	Interleukin-8 (Interleukin 8)IBA 10/2013
1	Prothrombin (Factor II)IBA 10/2013
1	C-Reactive ProteinIBA 10/2013
1	Interleukin-6 (Interleukin 6)IBA 10/2013
1	InterleukinsIBA 10/2013
1	Biological ProductsIBA 10/2013
1	Immunoglobulin M (IgM)IBA 10/2013
1	AntistreptolysinIBA 10/2013
1	Desmoglein 1IBA 06/2013
1	Prednisolone (Predate)FDA LinkGeneric 06/2013
1	Intravenous Immunoglobulins (IVIG)FDA Link 06/2013
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 06/2012
1	SmokeIBA 01/2011
1	Sucrose (Saccharose)IBA 01/2011
1	LigandsIBA 04/2010
1	Notch ReceptorsIBA 04/2010
1	CalciumIBA 11/2009
1	sairei-toIBA 11/2009
1	Nifedipine (Adalat)FDA LinkGeneric 11/2009
1	tempolIBA 11/2009
1	Superoxide DismutaseIBA 11/2009
1	Morphine (MS Contin)FDA LinkGeneric 09/2009
1	Biomarkers (Surrogate Marker)IBA 07/2009
1	Matrix Metalloproteinases (MMPs)IBA 01/2009
1	UracilIBA 02/2008

Therapy/Procedure

10	Therapeutics 03/2010 - 04/2000
1	Transplantation 09/2017
1	Lung Transplantation 09/2017
1	Plasmapheresis 06/2013
1	Self Administration (Administration, Self) 09/2009
1	Adjuvant Chemotherapy 02/2008